http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100464601-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate | 1998-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100464601-B1 |
| titleOfInvention | Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
| abstract | The present invention is directed to polar and / or charged amphiphiles with various modified amphiphilic macromolecules (polypeptides, proteins, etc.) or other chain molecules (e.g., partially hydrophobized suitable polynucleotides or polysaccharides, etc.) if necessary. Appropriate principles and procedures for the growth, testing, preparation and use of combinations with aggregates consisting of a mixture of materials and forming extended surfaces that can be freely suspended or supported are described. The agglomerates can be used after incorporating the described method with chain molecules that exhibit some activity or useful function, which may be used, for example, in vitro or in vivo, for example in drug delivery, diagnostics or bio / hydrolysis. It is suitable. In detail, a vesicle-shaped droplet mixture consisting of lipids containing (bound) insulin, interferon, interleukin, nerve growth factor, calcitonin, immunoglobulins, and the like is described. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160112915-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160112916-A |
| priorityDate | 1998-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 429.